Cancer of the oropharynx (Q34498121)

2 August 2017

1 reference

title

Cancer of the oropharynx. (English)

1 reference

2 August 2017

Lisa Licitra

1

1 reference

2 August 2017

Jacques Bernier

2

1 reference

2 August 2017

Cesare Grandi

3

1 reference

2 August 2017

Marco Merlano

4

1 reference

2 August 2017

Paolo Bruzzi

5

1 reference

2 August 2017

Jean-Louis Lefebvre

6

1 reference

2 August 2017

publication date

1 January 2002

1 reference

Critical Reviews in Oncology Hematology

2 August 2017

published in

1 reference

2 August 2017

volume

41

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

107-122

1 reference

Epidemiology and prevention of oral cancer

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Time Since Stopping Smoking and the Risk of Oral and Pharyngeal Cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Human papillomavirus in head and neck squamous cell carcinoma: are some head and neck cancers a sexually transmitted disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Molecular phenotyping of head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Hyperplasia, keratosis, dysplasia and carcinoma in situ of the vocal cords--a follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

The World Health Organization histological classification of tumours of the upper respiratory tract and ear. A commentary on the second edition.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Immunohistologic techniques in surgical pathology—A spectrum of “new” special stains

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Secondary lymphoma of Waldeyer's ring: natural history and association with prior extranodal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Regional metastasis in head and neck squamous cell carcinoma: revised value of US with US-guided FNAB.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

PET scanning in head and neck oncology: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Tumor volume: a basic and specific response predictor in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

The role of endoscopy in evaluating patients with head and neck cancer. A multi-institutional prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Symptom-directed selective endoscopy and cost containment for evaluation of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Synchronicity, multicentricity, and metachronicity of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Dental preservation in patients irradiated for head and neck tumours: A 10-year experience with topical fluoride and a randomized trial between two fluoridation methods

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: clinical and treatment parameters as prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Carcinoma of the tonsillar region: a multivariate analysis of 243 patients treated with radical radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Clinical radiobiology of squamous cell carcinoma of the oropharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Altered fractionation in the management of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Base-of-tongue carcinoma: treatment results using concomitant boost radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Postoperative radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: impact of therapy on patients with positive surgical margins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Chemotherapy as a substitute for surgery in the treatment advanced resectable head and neck cancer. A report from the Northern California Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Treatment of choice for squamous carcinoma of the tonsillar fossa

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Squamous cell carcinoma of the tonsillar area treated with radical irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Impact of neck node radioresponsiveness on the regional control probability in patients with oropharynx and pharyngolarynx cancers managed by definitive radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Carcinoma of the soft palate and anterior tonsillar pillar

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

The efficacy of comprehensive neck dissection with or without postoperative radiotherapy in nodal metastases of squamous cell carcinoma of the upper respiratory and digestive tracts

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Long-term treatment results of postoperative radiation therapy for advanced stage oropharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Radiation therapy for squamous cell carcinoma of the tonsillar region: a preferred alternative to surgery?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Organ-function preservation in advanced oropharynx cancer: results with induction chemotherapy and radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Surgical management of squamous cell carcinoma of the base of the tongue

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Base of tongue carcinoma: patterns of failure and predictors of recurrence after surgery alone

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Primary and salvage surgery for cancer of the tonsillar region: a retrospective study of 120 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Carcinoma of the tonsillar fossa. An update

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Composite resection with mandibulectomy in the treatment of posterolateral oral cavity and lateral oropharynx squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Surgery after organ preservation therapy. Analysis of wound complications

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Salvage brachytherapy of posterior pharyngeal wall squamous cell carcinoma in a previously irradiated area

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Elective radical neck dissection in epidermoid cancer of the head and neck. A retrospective analysis of 853 cases of mouth, pharynx, and larynx cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Distant metastases from head and neck squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Resection of pulmonary metastases from squamous carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Total glossectomy with laryngeal preservation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Planned early neck dissection before radiation for persistent neck nodes after induction chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Quality of life assessment in head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

The value of follow-up in patients treated for squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Follow-up study in head and neck cancer: cure rate according to tumor location and stage

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Follow-up in patients treated for head and neck cancer: how frequent, how thorough and for how long?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

Yearly chest radiography in the early detection of lung cancer following laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

The role of yearly chest radiography in the early detection of lung cancer following oral cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900129-9

7 January 2021

10.1016/S1040-8428(01)00129-9

Identifiers

DOI

1 reference

2 August 2017

1 reference